SEQUENTIAL KARYOTYPES IN NON-HODGKIN LYMPHOMA - THEIR NATURE AND SIGNIFICANCE

被引:36
作者
LEVINE, EG
JUNEJA, S
ARTHUR, D
GARSON, OM
MACHNICKI, JL
FRIZZERA, G
IRONSIDE, P
COOPER, I
HURD, DD
PETERSON, BA
MOSEL, D
BLOOMFIELD, CD
机构
[1] UNIV MINNESOTA,DEPT MED,MINNEAPOLIS,MN 55455
[2] UNIV MINNESOTA,DEPT PEDIAT,MINNEAPOLIS,MN 55455
[3] UNIV MINNESOTA,DEPT LAB MED & PATHOL,MINNEAPOLIS,MN 55455
[4] ST VINCENTS HOSP,DEPT CYTOGENET,SYDNEY,NSW 2010,AUSTRALIA
[5] PETER MACCALLUM CANC INST,DEPT HAEMATOL ONCOL,MELBOURNE,AUSTRALIA
[6] PETER MACCALLUM CANC INST,DEPT PATHOL,MELBOURNE,AUSTRALIA
关键词
D O I
10.1002/gcc.2870010403
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The examination of sequential karyotypes in hematologic disorders has demonstrated that karyotypic changes are often associated with concurrent changes in clinical behavior. Acquired abnormalities that recur among different patients may also suggest genomic areas important to tumor progression. We therefore examined sequential karyotypes in 21 patients with non‐Hodgkin lymphoma (NHL). Sixteen of the 21 karyotypes demonstrated changes, including the majority of 6 small lymphocytic, 11 follicular, and 4 intermediate and high‐grade diffuse lymphomas. The t(14;18)(q32;q21) occurred in ten initial karyotypes and was retained in all cases. The band most frequently affected by newly acquired abnormalities was 14q32 (n = 5); chromosomes 1 and 2 (n = 5, each), and the 17p arm (n = 4) were also commonly affected. The acquired deletion of all or part of 17p appeared to be associated with a poor prognosis. Histologic transformation and karyotypic change did not correlate. This study of sequential karyotypes in NHL 1) confirms the primary importance of the t(14;18), 2) suggests that the 14q32 band is involved frequently in both primary and secondary cytogenetic events, and 3) suggests other genomic regions of potential significance to progression. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:270 / 280
页数:11
相关论文
共 36 条
[1]  
[Anonymous], 1982, CANCER, V49, P2112
[2]   CORRELATION OF SECONDARY CYTOGENETIC ABNORMALITIES WITH HISTOLOGIC APPEARANCE IN NON-HODGKINS LYMPHOMAS BEARING T(14, 18)(Q32, Q21) [J].
ARMITAGE, JO ;
SANGER, WG ;
WEISENBURGER, DD ;
HARRINGTON, DS ;
LINDER, J ;
BIERMAN, PJ ;
VOSE, JM ;
PURTILO, DT .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (08) :576-580
[3]   CHROMOSOME-1 ABERRATIONS IN CANCER [J].
ATKIN, NB .
CANCER GENETICS AND CYTOGENETICS, 1986, 21 (04) :279-285
[4]   ADVANCED LYMPHOSARCOMA - INTENSIVE CYCLICAL COMBINATION CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, VINCRISTINE, AND PREDNISONE [J].
BAGLEY, CM ;
BERARD, CW ;
CANELLOS, GP ;
DEVITA, VT .
ANNALS OF INTERNAL MEDICINE, 1972, 76 (02) :227-+
[5]  
BLOOMFIELD CD, 1983, CANCER RES, V43, P2975
[6]   REPORT OF THE COMMITTEE ON STRUCTURAL CHROMOSOME CHANGES IN NEOPLASIA [J].
BLOOMFIELD, CD ;
TRENT, JM ;
VANDENBERGHE, H .
CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4) :344-366
[7]  
CABANILLAS F, 1986, P AM ASSOC CANC RES, V27, P198
[8]   ACTIVATION OF THE C-MYC ONCOGENE IN A PRECURSOR-B-CELL BLAST CRISIS OF FOLLICULAR LYMPHOMA, PRESENTING AS COMPOSITE LYMPHOMA [J].
DEJONG, D ;
VOETDIJK, BMH ;
BEVERSTOCK, GC ;
VANOMMEN, GJB ;
WILLEMZE, R ;
KLUIN, PM .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (21) :1373-1378
[9]  
DEVITA VT, 1975, LANCET, V1, P240
[10]  
FUKUHARA S, 1988, BLOOD, V71, P1748